Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Thermo Fisher Scientific; BD; DNA Genotek; Sigma-Aldrich; Analytik Jena; Biomedical Diagnostics; Two Blades Foundation, Bayer CropScience; Protea Biosciences

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific this week said that it has acquired Doe & Ingalls Management, a provider of production chemicals and customized supply chain services to the life sciences and microelectonic industries, for approximately $175 million in cash. The acquired firm, which had revenues of $110 million in 2011, will become part of Thermo Fisher's customer channels business within its Laboratory Products and Services segment.


Becton Dickinson disclosed this week in a regulatory filing that the firm paid $51 million, net of cash acquired, for Kiestra Lab Automation, a Dutch firm that makes lab automation solutions for microbiology labs. BD announced the deal in February but didn't provide financial details at the time.

Separately, BD said this week that it has opened a new distribution center in Four Oaks, NC. The $38 million, 720,000-square foot facility is expandable to more than 1.1 million square feet, said BD. It currently employs 140 people, and BD said that it expects the facility to generate 190 new jobs in the area.


Waters disclosed in its 10Q filing with the US Securities and Exchange Commission the purchase prices for two acquisitions it made earlier this year. The firm acquired the net assets of its Israel sales and service distributor for $6 million in cash, and it acquired Baehr Thermoanalyse for $12 million in cash and the assumption of $1 million of debt.


DNA Genotek announced the winners of its grant program. Paul Arnold of The Hospital for Sick Children will receive $30,000 and 260 Oragene DNA collection kits, and David Speicher of the Griffith Health Institute will receive $25,000 and 400 OmniGene Discover collection kits.


Sigma-Aldrich said this week that its board of directors has declared a quarterly cash dividend of $.20 per share. The dividend is payable on June 15 to holders of record on June 1.


Analytik Jena has opened an office in Dubai to strengthen its sales and service operations in the Middle East.


Biomedical Diagnostics has changed its name to Theradiag. The Paris-based firm said the name change reflects its new strategic direction in developing theranostic tests.


The Two Blades Foundation completed a non-exclusive license agreement with Bayer CropScience providing the agricultural products firm with access to its TAL Code technology for commercial uses in certain crop plants. The TAL Code enables tools to target specific loci in a genome and modulate the expression of genes.


Protea Biosciences Group has opened a new 10,000-suare-foot lab facility in Morgantown, W.Va., providing services that combine its own LAESI DP-1000 Direct Ionization System with Waters' Synapt G2-S high-definition mass spectrometer for biomolecular profiling.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more